Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 17:21 (324 d 08:57 ago) – Posting: # 21491
Views: 994

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.

Regards,
Ani

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 20 (0 registered, 20 guests [including 5 identified bots]).
Forum time: Monday 02:18 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5